Revive Therapeutics, Ltd.
3 clinical trials · Sponsor
◉ Watch Revive Therapeutics, Ltd.
| Record | Firm | Date |
|---|---|---|
| Bucillamine in Treatment of Patients With COVID-19 (NCT04504734) | Revive Therapeutics, Ltd. | 2020-11-27 |
Track Revive Therapeutics, Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.